NICO Progress Report
INN Open Neuroscience Forum
Agenda 2019
20 december - Ilaria Bertocchi (group Eva)
Fragile X Syndrome: pathophysiology and new therapeutic perspectives
11 december - Marina Boido (group Vercelli)
Nanoparticles and biomaterials as tools for the study and the treatment of spinal cord injury
29 november - Serena Stanga (group Vercelli)
The crucial role of mitochondria in neurodegenerative diseases: focus on Alzheimer's disease and Spinal Muscular Atrophy
4 october - Enrica Boda (group Buffo)
Are oligodendrocyte progenitors all born equal? A lesson from a microcephaly model.
20 september - Marco Fogli (groupo Peretto)
Transient neurogenic niches are generated by the sparse and asynchronous activation of striatal astrocytes after excitotoxic lesion
6 september -
Gianmarco Pallavicini
(Group Di Cunto)
Characterization of Citron kinase dead mice
26 july -
Roberta Parolisi
(Group Buffo)
Detrimental and protective action of microglial extracellular vesicles on myelin lesions
21 june -
Giulia Nato
(Group Buffo)
Neurogenic activation and lineage progression of striatal astrocytes following excitotoxic lesion
17 may - Valentina Cerrato (Group Buffo)
26 april - Iaria Balbo (Group Tempia)
Diet-based effects of PUFAs on a murine model of Spinocerebellar Ataxia 38 (SCA38)
5 april - Martina Lorenzati (group Buffo and Vercelli)
Allele specific silencing in ADLD: a proof-of-principle in OPCs and iPSCs-reprogrammed neurons
21 march - Brigitta Bonaldo (Group Panzica)
CHRONIC PERINATAL EXPOSURE TO BISPHENOL A: ANALYSIS OF THE EFFECTS IN EAE MODEL OF MULTIPLE SCLEROSIS
8 march - Francesca Montarolo (Group Bertolotto)
ADHD-like phenotypes in NURR1 knock-out mice
22 february - Isabella crisci (Group Peretto)
Fate mapping of adult hippocampal neural stem/progenitor cells in a model of neuroinflammation
8 February - Marilena Marraudino, PhD (Group Panzica)
GPER neuronal and glial cells expression in the hypothalamus of adult rats: sexual dimorphic distribution and differences during the estrous cycle
25 January - Roberta Schellino (Group Vercelli)
STEM CELL THERAPY FOR HD: WHEN THE ENVIRONMENTS MATTER